© 2021 MJH Life Sciences™ and Urology Times. All rights reserved.
Clinical care pathway demonstrates efficacy for patients with overactive bladder
February 2, 2021
Urology Times staff
Urology Times staff
Chris Du, MD, discusses findings from a study published in Neurourology and Urodynamics.
In this interview, Chris Du, MD, discusses findings from the Neurourology and Urodynamics paper, A retrospective longitudinal evaluation of new overactive bladder patients in an FPMRS urologist practice: Are patients following up and utilizing third‐line therapies?, for which he served as a study author. Du is a urology resident at Stony Brook University, Stony Brook, New York.
More videos:
Analysis underscores importance of pretreatment urine cultures in patients with recurrent UTI
A primer for urologists on statutes of limitations
Related Content:
